New radioactive drug targets thyroid tumors in early trial
Disease control
Recruiting now
This early-phase study is testing a new radioactive drug called 177Lu-CTR-FAPI in 12 people with thyroid cancer that has spread and is no longer responding to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors or slow the disease. Th…
Phase: PHASE1 • Sponsor: SHAOYAN LIU • Aim: Disease control
Last updated May 17, 2026 00:29 UTC